Unwanted accumulation of cellular debris and contaminants reduces throughput and product purity. Eliminating these obstructions prevents premature equipment failure and ensures consistent yield in continuous processing.

Suboptimal recovery and purity during large-scale viral vector or vaccine production. Improving throughput and particle integrity reduces manufacturing costs and clinical supply shortages.

Inaccurate or delayed detection of solvent impurities during purification leads to batch failure or safety risks. Real-time monitoring prevents product contamination and reduces processing delays.